Table 4.
Group | Treatment | Nonresponder | Responder | Total | p‐value |
---|---|---|---|---|---|
Age < 35 With varicocele |
Supplementation | 5 (27.8%) | 13 (72.2%) | 18 | .0601 |
Placebo | 8 (61.5%) | 5 (38.5%) | 13 | ||
Total | 13 | 18 | 31 | ||
Age < 35 Without varicocele |
Supplementation | 2 (12.5%) | 14 (87.5%) | 16 | .2715 |
Placebo | 5 (27.8%) | 13 (72.2%) | 18 | ||
Total | 7 | 27 | 34 | ||
BMI < 25 With varicocele |
Supplementation | 5 (25.0%) | 15 (75.0%) | 20 | .0066 |
Placebo | 13 (68.4%) | 6 (31.6%) | 19 | ||
Total | 18 | 21 | 39 | ||
BMI < 25 Without varicocele |
Supplementation | 4 (19.0%) | 17 (81.0%) | 21 | .7669 |
Placebo | 5 (22.7%) | 17 (77.3%) | 22 | ||
Total | 9 | 34 | 43 | ||
Age < 35 and BMI < 25 With varicocele |
Supplementation | 2 (15.4%) | 11 (84.6%) | 13 | .0078 |
Placebo | 7 (70.0%) | 3 (30.0%) | 10 | ||
Total | 9 | 14 | 23 | ||
Age < 35 and BMI < 25 Without varicocele |
Supplementation | 1 (7.7%) | 12 (92.3%) | 13 | .3533 |
Placebo | 3 (20.0%) | 12 (80.0%) | 15 | ||
Total | 4 | 24 | 28 |